首页> 外文期刊>Nutraceuticals World >CBD in Europe: News from the Front
【24h】

CBD in Europe: News from the Front

机译:欧洲的CBD:来自前面的新闻

获取原文
           

摘要

When industrial hemp first appeared on the radar in Europe, it was exempt from the scope of the UN’s Single Convention of 1961, meaning that, other than its relative marijuana, it was not per se considered a drug. Neither was its constituent cannabidiol (CBD) considered a narcotic, in contrast to the other famous hemp compound, tetrahydrocannabinol (THC), which is contained in industrial hemp in very small amounts only (below 0.3%). Varieties that contain 0.2% THC or less are legal to be cultivated in the EU. Any hemp product that contains more than that is considered a narcotic, and can therefore not be sold as a food or a food/dietary supplement.
机译:当工业大麻首先出现在欧洲的雷达上时,它豁免了联合国1961年的单一公约的范围,这意味着除了相对大麻之外,它不是本身认为是一种药物。 与其他着名的大麻化合物,四氢碱(THC)相比,其组成的大麻肽(CBD)也不是麻醉,其在工业大麻中仅以非常少量(低于0.3%)。 含有0.2%THC或更低的品种是合法的,可以在欧盟培养。 任何含量超过的大麻产品都被认为是麻醉,因此不能作为食物或食物/膳食补充剂出售。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号